Editorial: Towards continued and affordable accessibility of innovative drugs: sustainable development and efficient use of medicines

• Atse H. Huisman,
• Atse H. Huisman,
• Denise van den Berg,
• Saco de Visser,
• Bettina Ryll,
• Bettina Ryll,
• Sahar Barjesteh van Waalwijk van Doorn-Khosrovani,
• Sahar Barjesteh van Waalwijk van Doorn-Khosrovani

Affiliations

Atse H. Huisman

Department of Medical Oncology, Leiden University Medical Centre, Leiden, Netherlands

Atse H. Huisman

Department of Health Policy, Health Insurers Netherlands, Zeist, Netherlands

Denise van den Berg

Treatmeds Foundation, 's-Hertogenbosch, Netherlands

Saco de Visser

Centre for Future Affordable and Sustainable Therapy Development (FAST), The Hague, Netherlands

Bettina Ryll

Melanoma Patient Network Europe, Uppsala, Sweden

Bettina Ryll

Stockholm School of Economics Institute for Research, Stockholm, Sweden

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani

Department of Medical Oncology, Leiden University Medical Centre, Leiden, Netherlands

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani

Medical Department, CZ Health Insurance, Tilburg, Netherlands